New Jersey’s Medical Marijuana ‘Compromise’ Still Falls Short

New Jersey’s Medical Marijuana ‘Compromise’ Still Falls Short

New Jersey’s Medical Marijuana ‘Compromise’ Still Falls Short

by Mike Meno
December 6, 2010

New Jersey Gov. Chris Christie, who has spent much of the last year trying to weaken the medical marijuana law signed by his predecessor, announced new regulations Friday that made several concessions to patient advocates, but in many respects remain unjustly prohibitive. In either case, the latest proposal may finally allow for the first medical marijuana sales in New Jersey to take place as soon as this summer.

Under the new rules:

• New Jersey will become home to six legal growing sites and six distribution sites. (Christie originally wanted only two growers and four distributors.)
• Patients suffering from three “nonfatal” conditions – seizures, glaucoma, and intractable muscle spasms – will be required to exhaust all other treatment options before their doctor can recommend marijuana. (Christie originally wanted this cruel mandate to apply to allqualifying patients.)
• New Jersey will become the first medical marijuana state in the country to place an arbitrary cap (10 percent) on the level of THC allowed in all marijuana sold. (This is an unreasonable restriction for several reasons: THC is virtually nontoxic at any concentration, some patients may have better results with higher potency marijuana, and the pill Marinol, which is legal in all 50 states and approved by the FDA, is comprised of 100 percent THC.)
• Patients will still not be allowed to grow their own medicine. (Washington, D.C. is the only other medical marijuana jurisdiction with such a restriction.)
• The sales of marijuana-laced edibles will be prohibited, but items such as lozenges and skin ointments will be permitted.
• Only six marijuana plant strains will be allowed to be sold, further limiting the options for patients who might respond better to one specific strain over another.